Medications for Opioid Use Disorders in Incarcerated and Supervised Individuals
Author Information
Author(s): Kang Augustine W., Bailey Amelia, Surace Anthony, Stein Lynda, Rohsenow Damaris, Martin Rosemarie A.
Primary Institution: Center for Alcohol and Addiction Studies, Brown University School of Public Health
Hypothesis
How can the implementation of medications for opioid use disorder (MOUD) be improved among individuals under community supervision?
Conclusion
Enhancing access to evidence-based opioid use disorder treatment for individuals on community supervision is possible by engaging probation agencies and community treatment staff.
Supporting Evidence
- Medications for opioid use disorder significantly reduce opioid-related mortality.
- Only 10% of individuals needing treatment for opioid use disorder receive it while under community supervision.
- Community supervision provides a unique opportunity for early intervention in opioid use disorder treatment.
Takeaway
This study talks about how people on probation can get better help for their drug problems if the people in charge work together and understand their needs.
Methodology
In-depth individual interviews with key treatment providers and probation staff were conducted to explore perspectives on the provision of MOUD.
Potential Biases
Potential bias due to the small sample size and the specific context of the study.
Limitations
The study's findings may not be generalizable due to the specific structure of probation and parole in a single state.
Participant Demographics
{"average_age":47,"gender_distribution":{"male":7,"female":3},"race":{"white":10},"education":{"bachelor_degree":3,"master_degree_or_above":7}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website